Description: Otsuka Holdings Co., Ltd., through its subsidiaries, operates in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of central nervous system disorders, oncology, cardiovascular-renal, infectious disease, dermatological disease, gastroenterology, ophthalmology, diagnostics, surgical aid and regenerative, allergy/immunology, and urology. It also provides EQUELLE, a food product for women's health; BODYMAINTÉ Jelly, a conditioning food product; POCARI SWEAT, an electrolyte drink; Calorie Mate, a nutritional food product; SOYJOY, a soy bar; OS-1, an oral rehydration solution; HINE E-GEL, a concentrated liquid diet; PROCESSLEAD, a chew and swallow managing food product; REHADAYS, a beverage to support exercise and rehabilitation; Oronine H Ointment, a household antiseptic medicine; and vitamin tonics, herbal digestive drinks, and herbal crude drugs. In addition, the company offers soft drinks, foods, and wines; chemical materials for automotive, electrical, electronic, and building materials sectors; electronic equipment; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards and board arts, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; business information consultancy services; caps and ports for containers; and hydrazine. Otsuka Holdings Co., Ltd. was founded in 1921 and is headquartered in Tokyo, Japan.
Home Page: www.otsuka.com
2-9 Kanda-Tsukasamachi
Tokyo,
101-0048
Japan
Phone:
81 3 6717 1410
Officers
| Name | Title |
|---|---|
| Mr. Tatsuo Higuchi | CEO, President & Representative Director |
| Mr. Makoto Inoue | COO & Representative Director |
| Mr. Yoshiro Matsuo | Executive Deputy President & Executive Director |
| Mr. Masayuki Kobayashi | Executive Director |
| Ms. Yuko Makino | CFO & Executive Director |
| Akiko Ryu | Senior VP & Director of Human Resource Planning Department |
| Ms. Noriko Tojo | Executive Director |
| Mr. Shuichi Takagi | Executive Director |
| Chiaki Sakurai | Senior Vice President of Nutraceutical Business, Global Strategy & Planning Headquarters |
| Shigeko Takahashi | Senior VP and GM of Nutraceutical Business, Global Strategy & Planning Headquarters |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 13.4409 |
|---|---|
| Trailing PE: | 24.8302 |
| Price-to-Book MRQ: | 1.4357 |
| Price-to-Sales TTM: | 0.0112 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 34388 |